CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-10 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +6,256 | 136,564 | ||
| 2022-02-10 | Malamut Richard EVP and Chief Medical Officer | Shares withheld for taxes | −4,462 | $17.63 | $79K | 132,102 |
| 2022-02-10 | Malamut Richard EVP and Chief Medical Officer | Shares withheld for taxes | −1,838 | $17.63 | $32K | 130,264 |
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +45,500 | 87,500 | ||
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +4,212 | 91,712 | ||
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −2,821 | $17.63 | $50K | 88,891 |
| 2022-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −1,237 | $17.63 | $22K | 87,654 |
| 2022-02-10 | Ciaffoni Joseph President and CEO | Grant or award | +125,000 | 388,904 | ||
| 2022-02-10 | Ciaffoni Joseph President and CEO | Grant or award | +65,034 | 453,938 | ||
| 2022-02-10 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −24,154 | $17.63 | $426K | 429,784 |
| 2022-02-10 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −28,843 | $17.63 | $509K | 400,941 |
| 2022-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +56,700 | 145,956 | ||
| 2022-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +14,341 | 160,297 | ||
| 2022-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −6,967 | $17.63 | $123K | 153,330 |
| 2022-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −4,212 | $17.63 | $74K | 149,118 |
| 2022-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +52,500 | 128,769 | ||
| 2022-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +13,675 | 142,444 | ||
| 2022-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −6,643 | $17.63 | $117K | 135,801 |
| 2022-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −4,016 | $17.63 | $71K | 131,785 |
| 2022-01-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −701 | $19.05 | $13K | 76,269 |
Page 16 of 24 · 462 trades